A collaboration between scientists at Rutgers and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson’s disease, a neurodegenerative disorder with no cure that affects 1 million people in the United States. To read the full article.
Recent Posts
- New Study Raises Alarm Over Alzheimer’s Blood Tests.
- How a junk-food splurge can change your brain activity.
- Princeton Precision Health: An interdisciplinary, AI-driven approach to tackling big questions about health and disease.
- New NJACTS Publication
- Google Develops AI-Coscientist to Aid Researchers
Categories
- Community (2,179)
- Covid (983)
- CTO Events (6)
- News (2,784)
- Pilots (21)